果冻影院

XClose

果冻影院 News

Home
Menu

果冻影院 spin out Odin Vision acquired by Olympus to supercharge global growth

5 June 2023

Odin Vision, a 果冻影院 spin out company that develops AI-driven endoscopy technology to help better detect cancer, has been acquired by Olympus Corporation (Olympus) for up to 拢66 million.

Odin Vision

The company, spun out of research by 果冻影院 scientists, is a world-leading pioneer of cloud AI-enabled applications for endoscopy, that听enables clinicians to detect some early stage colorectal and oesophageal cancers. It was launched in 2019 with the support of 果冻影院 Business (果冻影院B), whichhelps academic entrepreneurs to commercialise IP, in the form of new businesses.

The acquisition deal will see Olympus acquire Odin鈥檚 entire portfolio of award-winning AI solutions, enabling Odin鈥檚 life-saving tools to reach millions of new patients around the world.

Commenting Peter Mountney, CEO of Odin Vision and Honorary Associate Professor at 果冻影院 Computer Science, said: 鈥淚'm incredibly proud of the team. We started with a university research project at 果冻影院 and transformed it into a commercial healthcare technology that will help millions around the world in the fight against cancer.鈥

Odin Vision began with the research of Patrick Brand茫o, Professor Danail Stoyanov and Professor Laurence Lovat, based at the 果冻影院 Wellcome / EPSRC Centre for Interventional and Surgical Sciences. Their pioneering work developed polyp detection systems which assisted doctors in the detection of colorectal cancer. With the support of 果冻影院B, 果冻影院鈥檚 commercialisation company, their research was then spun out and led to the founding of Odin Vision.

果冻影院 sits within a clinical-academic environment, meaning R&D in the lab can be inspired by and progressed with the support of a real-world outstanding clinical environment.

Dr Anne Lane, CEO of 果冻影院B, said: 鈥淲e are incredibly proud to see Odin Vision鈥檚 successful exit to Olympus. 果冻影院B has worked with Odin over a number of years to create a real-world impact from the research, through IP support and access to funding, as well as hands-on advice and guidance from the 果冻影院B team. Odin Vision鈥檚 success is testament to the hard work that goes on within our commercialisation team supporting spinouts to realise their full potential as they work to tackle society鈥檚 biggest challenges.鈥

果冻影院B also worked with AlbionVC to create 果冻影院 Tech Fund (果冻影院TF), who backed Odin Vision with early-stage funding in 2019. Using this backing, Odin Vision has proven the potential for patient impact in colorectal and oesophageal cancer detection in the UK, paving the way for an acquisition and exit that supercharges its impact. Odin Vision鈥檚 innovative software ultimately has the potential to save millions of pounds for the National Health Service.

David Grimm, Investment Director, 果冻影院TF added: 鈥Odin is a fantastic example of world-class research at 果冻影院 being backed with capital and support to enable their entrepreneurial journey. It鈥檚 been wonderful to work with this great team and be part of their journey from laboratory to real-world, scaled impact and outstanding financial return.鈥

Odin Vision also received support from 果冻影院鈥檚 Innovate UK EDGE, within 果冻影院 Innovation & Enterprise. Through the Innovate UK EDGE team, 果冻影院 assists high-growth businesses including trailblazing startups and research and development (R&D) intensive spinouts wanting to scale up and grow internationally, driving UK economic growth.

The successful acquisition of Odin Vision is yet another example of the UK鈥檚 commercialisation ecosystem at work. The UK is one of the premier locations for academic entrepreneurs to develop and commercialise game-changing innovation, with this successful exit worth up to 拢66 million now enabling a step forward in the detection of colorectal cancer.

Nacho Abia, Chief Operating Officer of Olympus said: 鈥淚ncorporating Odin Vision鈥檚 leading AI technology portfolio and innovation capabilities into the broader Olympus digital roadmap will create synergies that enable us to commercialize highly valuable endoscopy-focused software tools. Their product portfolio fits perfectly with our broader efforts to enhance the capabilities we bring in support of clinicians and to help care teams harness decision-driving data.鈥

听Links

Image

  • Odin Vision

Media contact

Kate Corry

Tel: +44 (0)20 3108 6995

Email: k.corry听[at] ucl.ac.uk